Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Acorda Therapeutics acquires Zanaflex rights from Elan

Aug. 2, 2004

New monoamine reuptake inhibitors discovered by Lilly researchers

Aug. 2, 2004

Ecgonine and ecgonidine analogues and their use reported by Entropin

Aug. 2, 2004

New data on mild cognitive impairment and its relationship with Alzheimer's disease

Aug. 2, 2004

Treatment with LXR agonist T-0901317 affects APP processing, ABCA1 upregulation and Abeta secretion

Aug. 2, 2004

Bifunctional drug inhibits beta-amyloid aggregation in vitro

Aug. 2, 2004

MRI improvements found with a single dose of natalizumab in relapsing MS patients

July 30, 2004

Completion of clinical portion of EXCEEDS phase IIIb study of Xyrem

July 30, 2004

Approvable letter for Ionsys

July 30, 2004

Inhibition of beta-amyloid plaque formation by Cu/Zn chelating agent

July 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...